Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
More about Open Access at the CrickAuthors list
Antoni Wrobel Donald Benton Saira Hussain Ruth Harvey Stephen R Martin Chloe Roustan Peter Rosenthal John J Skehel Steve GamblinAbstract
The CR3022 antibody, selected from a group of SARS-CoV monoclonal antibodies for its ability to cross-react with SARS-CoV-2, has been examined for its ability to bind to the ectodomain of the SARS-CoV-2 spike glycoprotein. Using cryo-electron microscopy we show that antibody binding requires rearrangements in the S1 domain that result in dissociation of the spike.
Journal details
Journal Nature Communications
Volume 11
Issue number 1
Pages 5337
Available online
Publication date
Full text links
Publisher website (DOI) 10.1038/s41467-020-19146-5
Figshare View on figshare
Europe PubMed Central 33087721
Pubmed 33087721
Keywords
Related topics
Type of publication